ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,771Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 517

$946K Total Retail Price of All Prescriptions

Rank: 23 out of 517

271 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

27% of this provider’s 271 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

58 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 772 719 1 1
TRAMADOL HCL 461 433 2 19
ZOLPIDEM TARTRATE 417 386 3 14
LEVOTHYROXINE SODIUM 397 353 4 6
DIOVAN 395 394 5 20
TAMSULOSIN HCL 372 324 6 22
METFORMIN HCL 364 326 7 4
VOLTAREN 355 350 8 69
AMLODIPINE BESYLATE 351 314 9 2
FAMOTIDINE 341 310 10 44
CRESTOR 308 295 11 27
OMEPRAZOLE 306 285 12 3
NEXIUM 306 264 12 29
ATORVASTATIN CALCIUM 275 264 14 12
DONEPEZIL HCL 270 260 15 28
GABAPENTIN 260 248 16 13
CARVEDILOL 252 249 17 26
DIOVAN HCT 251 245 18 31
METOPROLOL SUCCINATE 251 201 18 21
ENALAPRIL MALEATE 244 238 20 39
ALENDRONATE SODIUM 243 239 21 11
METOPROLOL TARTRATE 230 220 22 18
HYDROCODONE-ACETAMINOPHEN 206 183 S3 23 5
GLIMEPIRIDE 204 193 24 35
LIDODERM 194 167 25 49
PLAVIX 189 165 26 62
IBUPROFEN 182 160 27 16
SINGULAIR 181 138 28 64
ATENOLOL 173 173 29 8
ESCITALOPRAM OXALATE 172 167 30 93
FUROSEMIDE 168 164 31 9
ADVAIR DISKUS 161 123 32 46
MECLIZINE HCL 151 149 33 63
LYRICA 144 135 34 122
CLONIDINE HCL 144 131 34 59
PAROXETINE HCL 140 125 36 76
CELEBREX 139 110 37 40
CLOPIDOGREL 138 130 38 47
LOSARTAN POTASSIUM 133 115 39 17
MONTELUKAST SODIUM 129 100 40 130
JANUVIA 120 108 41 43
CYMBALTA 114 113 42 71
LIPITOR 112 96 43 81
BUSPIRONE HCL 105 105 44 121
FENOFIBRATE 104 82 45 75
AZITHROMYCIN 100 92 46 41
PROAIR HFA 99 98 47 33
LOSARTAN-HYDROCHLOROTHIAZIDE 98 89 48 50
IBANDRONATE SODIUM 98 93 48 129
BONIVA 96 93 50 165
DEXILANT 90 78 51 68
AVODART 90 85 51 99
MELOXICAM 87 78 53 25
ACETAMINOPHEN-CODEINE 86 81 S3 54 48
SPIRIVA 81 55 55 84
RAMIPRIL 80 55 56 97
PANTOPRAZOLE SODIUM 80 80 56 38
JANUMET 80 70 56 134
CLOBETASOL PROPIONATE 78 73 59 198
AMLODIPINE BESYLATE-BENAZEPRIL 74 74 60 65
ALLOPURINOL 74 62 60 37
LISINOPRIL 71 71 62 7
CILOSTAZOL 70 69 63 136
POTASSIUM CHLORIDE 68 64 64 34
DETROL LA 62 62 65 172
DICLOFENAC SODIUM 61 55 66 56
TRICOR 61 61 66 123
BENAZEPRIL HCL 59 57 68 15
GLYBURIDE 58 36 R 69 53
CIPROFLOXACIN HCL 57 51 70 74
OXYBUTYNIN CHLORIDE ER 57 57 70 141
CLOTRIMAZOLE-BETAMETHASONE 54 52 72 155
LEXAPRO 54 51 72 164
ISOSORBIDE MONONITRATE ER 51 51 74 70
ACTONEL 50 50 75 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.